[1] Ethier J, Mendelssohn DC, Elder SJ, et al.Vascular access use and outcomes: an international perspective from the Dialysis Outcomes and Practice Patterns Study[J]. Nephrol Dial Transplant,2008,23(10):3219-3226. [2] Vazquez MA.Vascular access for dialysis: recent lessons and new insights[J]. Curr Opin Nephrol Hypertens,2009, 18(2):116-121. [3] Vaux E, King J, Lloyd S, et al.Effect of buttonhole cannulation with a polycarbonate PEG on in-center hemodialysis fistula outcomes: a randomized controlled trial[J]. Am J Kidney Dis,2013,62(1):81-88. [4] Ball LK.The buttonhole technique for arteriovenous fistula cannulation[J]. Nephrol Nurs J,2006,33(3):299-304. [5] Stenvinkel P, Alvestrand A.Inflammation in end-stage renal disease: sources, consequences, and therapy[J]. Semin Dial,2002,15(5):329-337. [6] Yao Q, Axelsson J, Stenvinkel P, et al. Chronic systemic inflammation in dialysis patients: an update on causes and consequences[J]. ASAIO J,2004,50(6):lii-lvii. [7] van Hoek F, Scheltinga MR, Luirink M, et al. Access flow, venous saturation, and digital pressures in hemodialysis[J]. J Vasc Surg,2007,45(5):968-973. [8] Shyr YM, Su CH, Lui WY.Complications of continuous ambulatory peritoneal dialysis: one surgeon's experience with 668 patient-month follow-up[J]. Zhonghua Yi Xue Za Zhi (Taipei),1995,55(4):307-314. [9] Morena M, Delbosc S, Dupuy AM,et al.Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation[J]. Hemodial Int,2005,9(1):37-46. [10] Stenvinkel P, Heimbürger O, Paultre F,et al.Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure[J]. Kidney Int,1999,55(5):1899-1911. [11] Ballantyne CM, Nambi V.Markers of inflammation and their clinical significance[J]. Atheroscler Suppl,2005,6(2):21-29. [12] British Cardiac Society, British Hypertension Society, Diabetes UK, et al. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice[J]. Heart,2005,91 Suppl 5:v1-v52. |